STOCK TITAN

Coherus Management to Present at Upcoming Investor Conferences

Coherus BioSciences (Nasdaq: CHRS) announced their participation in two upcoming investor conferences in March 2021.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Coherus BioSciences (Nasdaq: CHRS) announced their participation in two upcoming investor conferences in March 2021. The 41st Annual Cowen Healthcare Conference will take place on March 1 at 4 p.m. ET, followed by the Barclays Global Healthcare Conference on March 9 at 1:15 p.m. ET. Investors can access the audio of these presentations on the Coherus BioSciences website. The company focuses on providing cost-effective medicines to improve patient care and reduce healthcare costs.

Loading...
Loading translation...
Argus Session date unavailable
-6.04% session move Open Argus
Details

News Market Reaction – CHRS

The recorded move for CHRS in the trading session of this news was -6.04%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

REDWOOD CITY, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will present at the following investor conferences in March.

  • 41st Annual Cowen Healthcare Conference on Monday, March 1 at 4 p.m. ET
  • Barclays Global Healthcare Conference on Tuesday, March 9 at 1:15 p.m. ET

The audio portion of the presentation will be available on the investors’ page of the Coherus BioSciences website at http://investors.coherus.com.

About Coherus BioSciences

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system.

For additional information, please visit www.coherus.com.

Contact
McDavid Stilwell
EVP, Financial Strategy and IR
Coherus BioSciences, Inc.
mstilwell@coherus.com
+1 (650) 395-0152

 


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Coherus BioSciences participate in the Cowen Healthcare Conference?

Coherus BioSciences will present at the 41st Annual Cowen Healthcare Conference on March 1, 2021, at 4 p.m. ET.

What is the date and time for Coherus BioSciences at the Barclays Global Healthcare Conference?

Coherus BioSciences will participate in the Barclays Global Healthcare Conference on March 9, 2021, at 1:15 p.m. ET.

Where can I listen to the audio presentations from Coherus BioSciences conferences?

The audio portion of the presentations will be available on the investors’ page of the Coherus BioSciences website.

What is the mission of Coherus BioSciences?

Coherus BioSciences aims to increase access to cost-effective medicines that significantly impact patients’ lives while delivering savings to the healthcare system.

Keep reading